The Intranasal Insulin Trial (INIT II) began in late 2006, and is being run by an Australian non-profit organization, the Diabetes Vaccine Development Centre (DVDC). The aim of the trial is to test a new preventative treatment for type 1 diabetes in young people who are at risk of developing this condition.